Silanol enzyme inhibitors
AssigneeThe Research Foundation of State University of New York
InventorsScott McN. Sieburth, Alfred M. Mutahi, Chien-An Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Research Foundation of State University of New York
InventorsScott McN. Sieburth, Alfred M. Mutahi, Chien-An Chen
Estimating the term…
Compounds of formula (I, II, or III), wherein X is OH; Y is OH, H, lower alkyl of one to six carbons or heteroatoms or F; Z and Z′ are independently H, lower alkyl or Q3Si where Q is lower alkyl or aryl; n is 3-50; n′ is 2-50, A and B are independently a) alkyl of one to ten carbons or heteroatoms, b) aryl of four to ten carbons or heteroatoms, c) cyclic of three to ten carbons or heteroatoms, or moieties of the formulas (d, e, or f); R1-R11 groups are each independently hydrogen, alkyl of one to ten carbons or heteoatoms aryl of 4 to 14 carbons or heteroatoms, arylalkyl of five to twenty carbons or heteroatoms; unsubstituted carbonyl or substituted carbonyl. Heteroatoms are nitrogen, oxygen, silicon or sulfur. At least one of A or B, or both A and B are d), e), or f). The compounds of formula (I) inhibit protease enzymes and can be used as pharmaceuticals.
A Human Immunodeficiency Virus (HIV) protease inhibitor of formula II
Dependencies are inferred from the claim text.